Sail Biomedicines
PrivateLast Round
Strategic
Jul 29, 2026
Total Funding Raised
$560.44M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Sail Biomedicines is a biotechnology company that develops a programmable medicine platform combining circular RNA technology and targeted nanoparticles with artificial intelligence to design and deploy medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sail Biomedicines Comparables
Compare Sail Biomedicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Circurna | 84% | |
| AbbVie | 84% | |
| RiboX Therapeutics | 84% |
For institutional investors. Book with your work email.
Sail Biomedicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jul 29, 2026 | ||||
| Grant | Dec 1, 2023 | ||||
| Grant | Dec 1, 2023 | ||||
| Series A | Oct 28, 2020 |
For institutional investors. Book with your work email.
Sail Biomedicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bill & Melinda Gates Foundation | Grant |
| Johnson & Johnson Innovation – JJDC | Strategic |
| Flagship Pioneering | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 32% MoM.
- Jul 29, 2026
$465M round led by Johnson & Johnson Innovation – JJDC.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingSep 4, 2026
Sail Biomedicines, Inc. enters a research partnership with Johnson & Johnson to develop in vivo CAR-T cell therapies for immune-mediated diseases at the platform/discovery stage, combining its AI-driven eRNA and targeted nanoparticle platform with Johnson & Johnson's clinical development, manufacturing, and commercialization capabilities in Q3 '26.
- receives_financingAug 19, 2026
On Aug 19th '26, Sail Biomedicines, Inc. could receive $140M in milestone payments from Johnson & Johnson if its programs reach certain development milestones, as part of a collaboration and acquisition arrangement.
For institutional investors. Book with your work email.
Sail Biomedicines Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sail Biomedicines's valuation, stock price, and market status.
Is Sail Biomedicines a public or private company?
Sail Biomedicines is a private company.
What is the current stock price of Sail Biomedicines?
Sail Biomedicines is a private company, so its shares have no public market price. Caplight tracks Sail Biomedicines's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sail Biomedicines worth (valuation)?
Valuation information for Sail Biomedicines is not publicly available.
Can I buy Sail Biomedicines stock?
Sail Biomedicines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sail Biomedicines's last funding round?
Sail Biomedicines's most recent funding round was Strategic on July 29, 2026.
Who are the main investors in Sail Biomedicines?
Key investors in Sail Biomedicines include Bill & Melinda Gates Foundation, Johnson & Johnson Innovation – JJDC, Flagship Pioneering.
Will Sail Biomedicines IPO soon?
No public IPO plans have been announced for Sail Biomedicines.
How can I track Sail Biomedicines secondary market activity?
Caplight tracks bids, offers, and trades in Sail Biomedicines's shares on secondary markets.